powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1134486046
Evan Lapinsky
MD
Hematology-Oncology
Newark,
DE
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 080001
Hospital
CCN 080004
Hospital
CCN 210032
Hospital
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$737
Payment records
33
By payment type
Food and Beverage
$650
Education
$87
Top paying entities
Food and Beverage
$650
Education
$87
PRESCRIBING · PART D · 2024
Total Rx claims
744
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
23
Brand share
25.1%
Top prescribed drugs
Anastrozole
101 claims
Apixaban
76 claims
Ondansetron Hcl
71 claims
Prochlorperazine Maleate
60 claims
Hydroxyurea
46 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,642
Unique beneficiaries
—
Total services
61,748
Distinct HCPCS
45
Medicare payment
$1.5M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 25 Hematology-Oncology providers in DE — top quintile (cohort median 969).
